April 20, 2017 wallstreetnation
Biotech & PharmaFeatured

VBIO issues breaking news on 4/20

Vitality Biopharma Releases Clinical Report of Cannabinoid Therapy for Pediatric IBD LOS ANGELES, CA–(Marketwired – Apr 20, 2017) – Vitality Biopharma, Inc. ( OTCQB : VBIO ) (“Vitality Biopharma”, “Vitality”, or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious … Continue reading “VBIO issues breaking news on 4/20”

Featured

Here’s the TOP Marijuana Stock You Haven’t Heard Of….YET!

The CANNABIS GREEN RUSH in on in Europe. The enormous volume of cash going into…

February 28, 2017 wallstreetnation